Aran F Labrijn
8PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 22, 2024
Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding.Nikolaus Frischauf, Jürgen Strasser, Ellen G F Borg
|Oct 16, 2023
The Influence of Human IgG Subclass and Allotype on Complement Activation.Timon Damelang, Steven W de Taeye, Rosa Rentenaar
|Mar 30, 2023
Mutation of the TGN1412 anti-CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super-agonist activity.Alicia M Chenoweth, Sandra Esparon, Bruce D Wines
|Sep 12, 2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.Odd L Gammelgaard, Mikkel G Terp, Christian Renn
|Jan 20, 2021
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors.Jim Middelburg, Kristel Kemper, Patrick Engelberts
|Jun 09, 2019
Bispecific antibodies: a mechanistic review of the pipeline.Aran F Labrijn, Maarten L Janmaat, Janice M Reichert
Pageof 2
Frequent Collaborators
4 joint publications
Janine Schuurman
4 joint publications
Paul Whi Parren
1 joint publications
Mario Losen
1 joint publications
Krista G Haanstra
1 joint publications
Joyce I Meesters
1 joint publications
Maarten L Janmaat
1 joint publications
Janice M Reichert
1 joint publications
Jim Middelburg
1 joint publications
Patrick Engelberts
1 joint publications
Thorbald van Hall
